Skip to main content
. 2022 Feb 12;37(3):541–551. doi: 10.1007/s00384-022-04105-x

Table 2.

Median follow-up periods for the second primary cancers included in the meta-analysis

Second cancer Median follow-up years (IQR)
Urinary bladder 4.2 (3.8–12.1)
Brain 12.1
Breast 4.2 (3.8–12.1)
Cervix 5.7
Female genital 4.0 (3.5–16.8)
Gallbladder 7.3
Kidney 4.2 (3.8–12.1
Leukaemia 12.1
Liver, hepatic duct, and biliary 4.0 (3.5–7.3)
Lung, bronchus, and mediastinum 4.2 (3.8–12.1)
Melanoma 4.1 (3.9–9.7)
Myeloma 5.8
Non-Hodgkin lymphoma 10.5
Oesophagus 5.7 (3.6–14.4)
Ovary 7.3 (4.0–16.8)
Pancreas 4.1 (3.5–9.7)
Prostate 4.2 (3.8–12.1)
Small intestine 4.2 (3.5–7.3)
Stomach 4.2 (3.8–12.1
Thyroid 7.0 (4.0–7.3)
Upper aerodigestive tract 7.3 (3.5–16.8)
Uterus 4.2 (3.8–12.1)